The global disposable endoscopes market size is expected to reach a valuation of US$ 1.3 billion by the end of 2023 and is predicted to expand at a CAGR of 17.7% from 2023 to 2033. The global market is projected to reach a valuation of US$ 6.8 billion by 2033.
Disposable endoscopes are becoming a simple solution for the growing problem of infections acquired during surgical procedures globally. The availability of various medical devices such as bronchoscopes, cystoscopes, esophagoscopes, hysteroscopes, laryngoscopes, and proctoscopes might drive the global market. A few other vital driving factors of the global market include
Incidence of chronic diseases and their diagnosis rates are increasing, including biopsy, in which endoscopes are immensely used.
Research and development activities lead to various innovative products' development through modifications. Moreover, key players are extensively utilizing many new materials, such as silicone, polyurethane, and rubber, to make the endoscope device sturdier than its counterparts.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global market is set to present an opportunistic outlook due to disposable endoscopes' high functionality and usability. Endoscopic or minimally invasive or keyhole procedures are the future of surgery.
The prevalence of chronic diseases and their identification involves diagnosis, which could create an opportunity to use endoscopes. It is mainly driven by low costs and technological advancements, which are vital criteria for inventors and manufacturers of innovative products.
Endoscope covers multiple medical segments, including ENT, respiratory, urology, cardiovascular, and joint surgeries. Hence, the adoption rate of these devices is high worldwide. The recent rise in life-threatening infectious diseases also fuels growth in the disposable endoscopes market.
Conventional endoscopes have a high chance of recurrent infections acquired either endogenously or exogenously. These infectious agents can contaminate the endoscopic equipment due to improper reprocessing or even during a surgical session, either from the patient to the surgeon or vice versa. The chances of these problems are reduced with the adoption of disposable endoscopes.
The emergence of low-cost video capsules or nanorobots that can be applied for therapy, biopsy, or tagging is anticipated to propel positive procedural rates when combined with standard endoscopic procedures.
Disposable endoscopes gained traction in the global healthcare sector over the past decade. In addition, the equipment is an added investment for healthcare settings already using conventional endoscopes, which may hamper the market in the next decade.
Disposable endoscopes contribute to large volumes of medical waste, especially plastic as they are meant for single use. According to the World Health Organization (2018), about 85% of the total waste produced by healthcare activities is a standard, non-hazardous waste. Also, the residual 15% is classified as hazardous material, which could be toxic, radioactive, or infectious.
Since plastic microparticles have lately been found in human feces and blood, this could become an environmental hazard. Europe recently took on this problem and outlawed single-use plastics. Hence, stringent restrictions controlling the adoption of disposable endoscopes due to plastic bans in high and low-economy countries can hamper the market.
| Attributes | Details |
|---|---|
| Market CAGR (2023 to 2033) | 17.7% |
| Market Valuation (2023) | US$ 1.3 billion |
| Market Valuation (2033) | US$ 6.8 billion |
Principal Consultant
The global endoscopy market was valued at US$ 44.8 billion in 2022. As per FMI, the market for disposable endoscopes expanded at a CAGR of around 13.7% from 2018 to 2022.
The rising number of surgical procedures, increasing aging population, and surging adoption of technologically advanced products are driving the market. Further, developing low-cost single-use endoscopes with one-time-use features and enhanced functionality might also cut the overall cost burden in healthcare facilities.
Conventional endoscopes are expensive. For both doctors and nurses, the use of conventional endoscopes requires high levels of training and expertise, particularly for treatments. These endoscopes involve high reprocessing costs such as disinfection, surveillance, maintenance, and repair.
Reprocessing ensures that the device is devoid of any kind of pathogens. But, definitive steps have been taken to control infections occurring due to contamination and low patient death related to reusable endoscopes.
In a study conducted by the USA Food and Drug Administration (FDA) in 2021, three deaths occurred from bacterial infections linked to urinary endoscopes, posing a high concern for patient safety.
Customized device manufacturing companies and infection control teams in medical facilities focus on the growth of original equipment manufacturers (OEM). They usually supply high-tech cameras to achieve better-resolution images that can cut production costs and time.
Disruptive technology and affordability in disposable endoscopes are also expected to spur industry growth. Owing to the factors above, the global market is expected to grow at a CAGR of 16.3% from 2023 to 2033.
Need for Minimally Invasive Surgeries in the United States is to Push Sales of Disposable Flexible Endoscopes
The United States dominated the global disposable endoscopes market and generated a total share of about 30.2% in 2023. It is expected to continue to showcase the same growth throughout the forecast period, says FMI.
A growing aging population, the urgent need for minimally invasive surgeries, and the rising prevalence of infectious diseases are some factors boosting the United States market. According to a multisite study conducted by the American Journal of Infection Control in 2018, microbial growth was discovered in 71% of endoscope samples.
Improper reprocessing and unsatisfactory drying contributed to residual fluid and contamination. Backed by the abovementioned factors, demand for disposable endoscopes is estimated to continue to increase in the United States, thereby supporting the market.
Rising Prevalence of Cancer in Germany is Estimated to Fuel Demand for Single-use Endoscopes
Germany exhibited a share of around 4.4% in Europe’s disposable endoscopes market in 2023. The country has a well-established healthcare system. The country's availability of advanced healthcare facilities attracts patients from all over the globe.
The presence of skilled healthcare professionals and rising demand for safe & innovative treatment options from patients are likely to aid Germany’s market. The incidence of functional gastrointestinal disorders and several chronic diseases such as cancer, diabetes, and cardiovascular disorders has increased the diagnosis rates, thereby escalating the adoption rate of disposable endoscopes.
The Robert Koch Institute concluded that 265,000 men and 233,000 women reportedly received a new cancer diagnosis in 2018. These numbers are anticipated to grow significantly owing to the reasons such as:
These companies are projected to come up with effective and multipurpose disposable endoscopes.
The Growing Geriatric Population is Anticipated to Bolster Sales of Disposable Laryngoscopes in China
China is one of the leading manufacturers of disposable endoscopes. The country held a CAGR of around 22.2% in 2023 and is anticipated to grow significantly over the forecast period. Growth is mainly attributed to the ongoing development of new healthcare facilities in the country and the presence of prominent manufacturers.
China is one of the most populated countries in the world. Increasing the requirement for novel healthcare services and the growing geriatric population would create a new growth opportunity for disposable endoscope manufacturers in the country. Besides, multinational companies are targeting China to develop their facilities with the easy availability of low-cost labor and raw materials.
The increasing geriatric population in the country might push sales during the evaluation period. According to the World Health Organization (WHO), 254 million people were 60 years and above in China in 2019, and 176 million were 65 years and older. It is projected to increase the prevalence of various chronic diseases, thereby driving the market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Disposable Bronchoscopes to Gain Impetus with Rising Prevalence of COPD
Disposable bronchoscopes are expected to record high growth at a CAGR of 18.1% by the end of the forecast period. The segment held a market share of about 30.1% globally in 2021. Disposable bronchoscopes are popular worldwide owing to their increasing adoption in diagnosing respiratory disorders such as chronic obstructive pulmonary disease (COPD) and asthma, which would further accelerate growth.
Hospitals to Deploy Innovative Disposable Duodenoscopes
Hospitals held the high market share of about 62.2% in 2021, finds FMI. Low procedural costs, reduced risk of contamination, and better clinical outcomes in hospital settings drive this segment, thereby propelling sales of disposable endoscopes.
The market is highly fragmented, with several competitors in the disposable endoscope production sphere. To meet the rising consumer demand and expand their customer base, these companies are implementing various strategies such as mergers & acquisitions, partnerships, collaborations, and new product launches.
Recent Industry Developments
| Attributes | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | US$ billion for Value |
| Key Countries Covered | The United States, The United Kingdom, Japan, India, China, Australia, Germany |
| Key Segments Covered | Product, End User, Region |
| Key Companies Profiled | Ambu A/S; EndoLook; Medtronic Plc; HOYA Corporation; Flexicare Medical Limited |
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The Asia Pacific region is projected to emerge as a lucrative market for disposable endoscopes.
The growth potential of the disposable endoscopes market is 17.7% through 2033.
The high cost of adoption is likely to limit market growth.
North America is likely to generate 25% revenue in 2023.
The global market size to reach US$ 6.8 billion by 2033.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product, 2023 to 2033 5.3.1. Bronchoscopes 5.3.2. Cystoscopes 5.3.3. Duodenoscopes 5.3.4. Esophagoscopes 5.3.5. Hysteroscopes 5.3.6. Laryngoscopes 5.3.7. Proctoscopes 5.3.8. Ureteroscopes 5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033 6.3.1. Hospitals 6.3.2. Ambulatory Surgical Center 6.3.3. Diagnostic Center 6.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022 7.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033 7.3.1. North America 7.3.2. Latin America 7.3.3. Western Europe 7.3.4. Eastern Europe 7.3.5. South Asia and Pacific 7.3.6. East Asia 7.3.7. Middle East and Africa 7.4. Market Attractiveness Analysis By Region 8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 8.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 8.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 8.2.1. By Country 8.2.1.1. USA 8.2.1.2. Canada 8.2.2. By Product 8.2.3. By End User 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Product 8.3.3. By End User 8.4. Key Takeaways 9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. Brazil 9.2.1.2. Mexico 9.2.1.3. Rest of Latin America 9.2.2. By Product 9.2.3. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product 9.3.3. By End User 9.4. Key Takeaways 10. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Germany 10.2.1.2. UK 10.2.1.3. France 10.2.1.4. Spain 10.2.1.5. Italy 10.2.1.6. Rest of Western Europe 10.2.2. By Product 10.2.3. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product 10.3.3. By End User 10.4. Key Takeaways 11. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Poland 11.2.1.2. Russia 11.2.1.3. Czech Republic 11.2.1.4. Romania 11.2.1.5. Rest of Eastern Europe 11.2.2. By Product 11.2.3. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product 11.3.3. By End User 11.4. Key Takeaways 12. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. India 12.2.1.2. Bangladesh 12.2.1.3. Australia 12.2.1.4. New Zealand 12.2.1.5. Rest of South Asia and Pacific 12.2.2. By Product 12.2.3. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product 12.3.3. By End User 12.4. Key Takeaways 13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. China 13.2.1.2. Japan 13.2.1.3. South Korea 13.2.2. By Product 13.2.3. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product 13.3.3. By End User 13.4. Key Takeaways 14. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. GCC Countries 14.2.1.2. South Africa 14.2.1.3. Israel 14.2.1.4. Rest of MEA 14.2.2. By Product 14.2.3. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product 14.3.3. By End User 14.4. Key Takeaways 15. Key Countries Market Analysis 15.1. USA 15.1.1. Pricing Analysis 15.1.2. Market Share Analysis, 2022 15.1.2.1. By Product 15.1.2.2. By End User 15.2. Canada 15.2.1. Pricing Analysis 15.2.2. Market Share Analysis, 2022 15.2.2.1. By Product 15.2.2.2. By End User 15.3. Brazil 15.3.1. Pricing Analysis 15.3.2. Market Share Analysis, 2022 15.3.2.1. By Product 15.3.2.2. By End User 15.4. Mexico 15.4.1. Pricing Analysis 15.4.2. Market Share Analysis, 2022 15.4.2.1. By Product 15.4.2.2. By End User 15.5. Germany 15.5.1. Pricing Analysis 15.5.2. Market Share Analysis, 2022 15.5.2.1. By Product 15.5.2.2. By End User 15.6. UK 15.6.1. Pricing Analysis 15.6.2. Market Share Analysis, 2022 15.6.2.1. By Product 15.6.2.2. By End User 15.7. France 15.7.1. Pricing Analysis 15.7.2. Market Share Analysis, 2022 15.7.2.1. By Product 15.7.2.2. By End User 15.8. Spain 15.8.1. Pricing Analysis 15.8.2. Market Share Analysis, 2022 15.8.2.1. By Product 15.8.2.2. By End User 15.9. Italy 15.9.1. Pricing Analysis 15.9.2. Market Share Analysis, 2022 15.9.2.1. By Product 15.9.2.2. By End User 15.10. Poland 15.10.1. Pricing Analysis 15.10.2. Market Share Analysis, 2022 15.10.2.1. By Product 15.10.2.2. By End User 15.11. Russia 15.11.1. Pricing Analysis 15.11.2. Market Share Analysis, 2022 15.11.2.1. By Product 15.11.2.2. By End User 15.12. Czech Republic 15.12.1. Pricing Analysis 15.12.2. Market Share Analysis, 2022 15.12.2.1. By Product 15.12.2.2. By End User 15.13. Romania 15.13.1. Pricing Analysis 15.13.2. Market Share Analysis, 2022 15.13.2.1. By Product 15.13.2.2. By End User 15.14. India 15.14.1. Pricing Analysis 15.14.2. Market Share Analysis, 2022 15.14.2.1. By Product 15.14.2.2. By End User 15.15. Bangladesh 15.15.1. Pricing Analysis 15.15.2. Market Share Analysis, 2022 15.15.2.1. By Product 15.15.2.2. By End User 15.16. Australia 15.16.1. Pricing Analysis 15.16.2. Market Share Analysis, 2022 15.16.2.1. By Product 15.16.2.2. By End User 15.17. New Zealand 15.17.1. Pricing Analysis 15.17.2. Market Share Analysis, 2022 15.17.2.1. By Product 15.17.2.2. By End User 15.18. China 15.18.1. Pricing Analysis 15.18.2. Market Share Analysis, 2022 15.18.2.1. By Product 15.18.2.2. By End User 15.19. Japan 15.19.1. Pricing Analysis 15.19.2. Market Share Analysis, 2022 15.19.2.1. By Product 15.19.2.2. By End User 15.20. South Korea 15.20.1. Pricing Analysis 15.20.2. Market Share Analysis, 2022 15.20.2.1. By Product 15.20.2.2. By End User 15.21. GCC Countries 15.21.1. Pricing Analysis 15.21.2. Market Share Analysis, 2022 15.21.2.1. By Product 15.21.2.2. By End User 15.22. South Africa 15.22.1. Pricing Analysis 15.22.2. Market Share Analysis, 2022 15.22.2.1. By Product 15.22.2.2. By End User 15.23. Israel 15.23.1. Pricing Analysis 15.23.2. Market Share Analysis, 2022 15.23.2.1. By Product 15.23.2.2. By End User 16. Market Structure Analysis 16.1. Competition Dashboard 16.2. Competition Benchmarking 16.3. Market Share Analysis of Top Players 16.3.1. By Regional 16.3.2. By Product 16.3.3. By End User 17. Competition Analysis 17.1. Competition Deep Dive 17.1.1. Ambu A/S 17.1.1.1. Overview 17.1.1.2. Product Portfolio 17.1.1.3. Profitability by Market Segments 17.1.1.4. Sales Footprint 17.1.1.5. Strategy Overview 17.1.1.5.1. Marketing Strategy 17.1.1.5.2. Product Strategy 17.1.1.5.3. Channel Strategy 17.1.2. Olympus America 17.1.2.1. Overview 17.1.2.2. Product Portfolio 17.1.2.3. Profitability by Market Segments 17.1.2.4. Sales Footprint 17.1.2.5. Strategy Overview 17.1.2.5.1. Marketing Strategy 17.1.2.5.2. Product Strategy 17.1.2.5.3. Channel Strategy 17.1.3. Boston Scientific Corporation 17.1.3.1. Overview 17.1.3.2. Product Portfolio 17.1.3.3. Profitability by Market Segments 17.1.3.4. Sales Footprint 17.1.3.5. Strategy Overview 17.1.3.5.1. Marketing Strategy 17.1.3.5.2. Product Strategy 17.1.3.5.3. Channel Strategy 17.1.4. Fujifilm Holdings Corporation 17.1.4.1. Overview 17.1.4.2. Product Portfolio 17.1.4.3. Profitability by Market Segments 17.1.4.4. Sales Footprint 17.1.4.5. Strategy Overview 17.1.4.5.1. Marketing Strategy 17.1.4.5.2. Product Strategy 17.1.4.5.3. Channel Strategy 17.1.5. NeoScope Inc. 17.1.5.1. Overview 17.1.5.2. Product Portfolio 17.1.5.3. Profitability by Market Segments 17.1.5.4. Sales Footprint 17.1.5.5. Strategy Overview 17.1.5.5.1. Marketing Strategy 17.1.5.5.2. Product Strategy 17.1.5.5.3. Channel Strategy 17.1.6. Coloplast Corp 17.1.6.1. Overview 17.1.6.2. Product Portfolio 17.1.6.3. Profitability by Market Segments 17.1.6.4. Sales Footprint 17.1.6.5. Strategy Overview 17.1.6.5.1. Marketing Strategy 17.1.6.5.2. Product Strategy 17.1.6.5.3. Channel Strategy 17.1.7. Endotherapeutics Pty Ltd 17.1.7.1. Overview 17.1.7.2. Product Portfolio 17.1.7.3. Profitability by Market Segments 17.1.7.4. Sales Footprint 17.1.7.5. Strategy Overview 17.1.7.5.1. Marketing Strategy 17.1.7.5.2. Product Strategy 17.1.7.5.3. Channel Strategy 17.1.8. Laborie 17.1.8.1. Overview 17.1.8.2. Product Portfolio 17.1.8.3. Profitability by Market Segments 17.1.8.4. Sales Footprint 17.1.8.5. Strategy Overview 17.1.8.5.1. Marketing Strategy 17.1.8.5.2. Product Strategy 17.1.8.5.3. Channel Strategy 17.1.9. Shenzhen Tianlang Medical 17.1.9.1. Overview 17.1.9.2. Product Portfolio 17.1.9.3. Profitability by Market Segments 17.1.9.4. Sales Footprint 17.1.9.5. Strategy Overview 17.1.9.5.1. Marketing Strategy 17.1.9.5.2. Product Strategy 17.1.9.5.3. Channel Strategy 17.1.10. Intersurgical 17.1.10.1. Overview 17.1.10.2. Product Portfolio 17.1.10.3. Profitability by Market Segments 17.1.10.4. Sales Footprint 17.1.10.5. Strategy Overview 17.1.10.5.1. Marketing Strategy 17.1.10.5.2. Product Strategy 17.1.10.5.3. Channel Strategy 17.1.11. Teleflex Incorporated. 17.1.11.1. Overview 17.1.11.2. Product Portfolio 17.1.11.3. Profitability by Market Segments 17.1.11.4. Sales Footprint 17.1.11.5. Strategy Overview 17.1.11.5.1. Marketing Strategy 17.1.11.5.2. Product Strategy 17.1.11.5.3. Channel Strategy 17.1.12. Bell Medical Inc. 17.1.12.1. Overview 17.1.12.2. Product Portfolio 17.1.12.3. Profitability by Market Segments 17.1.12.4. Sales Footprint 17.1.12.5. Strategy Overview 17.1.12.5.1. Marketing Strategy 17.1.12.5.2. Product Strategy 17.1.12.5.3. Channel Strategy 17.1.13. PENTAX Medical 17.1.13.1. Overview 17.1.13.2. Product Portfolio 17.1.13.3. Profitability by Market Segments 17.1.13.4. Sales Footprint 17.1.13.5. Strategy Overview 17.1.13.5.1. Marketing Strategy 17.1.13.5.2. Product Strategy 17.1.13.5.3. Channel Strategy 17.1.14. CooperSurgical Inc. 17.1.14.1. Overview 17.1.14.2. Product Portfolio 17.1.14.3. Profitability by Market Segments 17.1.14.4. Sales Footprint 17.1.14.5. Strategy Overview 17.1.14.5.1. Marketing Strategy 17.1.14.5.2. Product Strategy 17.1.14.5.3. Channel Strategy 17.1.15. Meditrina Inc. 17.1.15.1. Overview 17.1.15.2. Product Portfolio 17.1.15.3. Profitability by Market Segments 17.1.15.4. Sales Footprint 17.1.15.5. Strategy Overview 17.1.15.5.1. Marketing Strategy 17.1.15.5.2. Product Strategy 17.1.15.5.3. Channel Strategy 17.1.16. UroViu Corporation 17.1.16.1. Overview 17.1.16.2. Product Portfolio 17.1.16.3. Profitability by Market Segments 17.1.16.4. Sales Footprint 17.1.16.5. Strategy Overview 17.1.16.5.1. Marketing Strategy 17.1.16.5.2. Product Strategy 17.1.16.5.3. Channel Strategy 17.1.17. Adler MicroMed Inc. 17.1.17.1. Overview 17.1.17.2. Product Portfolio 17.1.17.3. Profitability by Market Segments 17.1.17.4. Sales Footprint 17.1.17.5. Strategy Overview 17.1.17.5.1. Marketing Strategy 17.1.17.5.2. Product Strategy 17.1.17.5.3. Channel Strategy 17.1.18. Advin Health Care 17.1.18.1. Overview 17.1.18.2. Product Portfolio 17.1.18.3. Profitability by Market Segments 17.1.18.4. Sales Footprint 17.1.18.5. Strategy Overview 17.1.18.5.1. Marketing Strategy 17.1.18.5.2. Product Strategy 17.1.18.5.3. Channel Strategy 17.1.19. KARL STORZ SEASON 17.1.19.1. Overview 17.1.19.2. Product Portfolio 17.1.19.3. Profitability by Market Segments 17.1.19.4. Sales Footprint 17.1.19.5. Strategy Overview 17.1.19.5.1. Marketing Strategy 17.1.19.5.2. Product Strategy 17.1.19.5.3. Channel Strategy 18. Assumptions & Acronyms Used 19. Research Methodology
Explore Healthcare Insights
View Reports
Disposable Endoscopes Market
